Anatomy of a heart attack – goskagit.com

HEART ATTACKS HAPPEN to both women and menbut they dont always look the same. Theyre not as obvious as youd see on TV, and thats true for more women than men.

Heres a look at what makes recognizing a heart attack so importantand why noticing more subtle signs is especially important for women.

What to look for

What does a heart attack feel like? Chest pain or discomfort is the most common symptom for both women and men. The pain may last a few minutes or come and go. Some people say it feels like pressure, squeezing, or fullness. Or it may feel like an upset stomach or heartburn.

But women are more likely than men to have other heart attack signs, says Paul Connor, MD, PeaceHealth Medical Group Cardiology, in Bellingham.

Those may include:

Shortness of breath with or without chest pain

Nausea, lightheadedness, or vomiting

Unexplained fatigue that may last for days

Back, shoulder, arm or jaw pain

Women are also at higher risk for silent heart attacks, according to some studies. This is when symptoms of a heart attack are so mild that they go unnoticedor are dismissed as anxiety.

Silent heart attacks are just as dangerous as more obvious heart attacks, though, says Dr. Connor. Left untreated, they can cause scarring and permanent damage, raising the risk of other heart problems.

So dont be too quick to dismiss shortness of breath or lightheadedness as just anxiety. And make sure you tell medical professionals that you think youre having a heart attack, not an anxiety attack.

A supply problem at the pump

Despite womens more subtle symptoms, the mechanics of a heart attack are fundamentally the same for both sexes. It happens when the hearts blood supply is reduced or cut off, most often when an artery becomes blocked.

What usually sets the stage? Doctors call it atherosclerosis. It happens when arteries that bring blood to the heart slowly become clogged with plaque. A blood clot can form around these plaques, causing complete obstruction of the blood flow to the heart muscle.

Without prompt treatment, areas of heart muscle may die and eventually be replaced by scars. This damage could leave a heart attack survivor with a weakened heart.

And a weak heart may not be able to pump blood to the bodys organs like it should, which could result in other quality-of-life issues, Dr. Connor says.

Quick treatment can restore blood flow to the heart and help prevent damage. So be aware of these warning signs for both yourself and others. If theres even a slight chance you could be having a heart attack, dont wait. Call 911 and get to a hospital to give your heart the best chance.

See more here:
Anatomy of a heart attack - goskagit.com

Anatomy class teaches several lessons – Seguin Gazette: Editorials – Seguin Gazette-Enterprise

Recently, a group of high school students, under the direction of anatomy teacher Daniel Sanchez visited Vogel Elementary and taught all of the second grade students a little lesson.

The subject a human cell.

While this may seem a little outside the younger students realm of understanding, the teens delivered the lesson in a way the youngsters could understand.

Prior to the visit, Sanchez, wanted to make sure his students understood the lesson and tasked them with writing a childrens story.

By using the terminology and definitions, his students received an easier way to remember what they have learned.

What he didnt expect to happen was to see that lesson evolve beyond his classroom, and spill over into the elementary classroom.

As Sanchez students read their stories to the second graders, the children eagerly listened and then asked questions.

They also got to see what a human cell looks like thanks to the models the teens also created for their class, unknowing that it would become a prop for this special session.

Not only did the high school students learn, but they taught their younger counterparts, solidifying what they learned.

They became role models for the younger students, and helped them engage in conversations.

They created a new curiosity for science, and quite possibly an interest that can lead to things beyond what they imagined.

Our Voice is the opinion of the Seguin Gazette editorial board.

Continue reading here:
Anatomy class teaches several lessons - Seguin Gazette: Editorials - Seguin Gazette-Enterprise

Seattle Genetics Earnings: Waiting on ECHELON – Motley Fool

2017 is looking like a transition year for the biotech.

Seattle Genetics (NASDAQ:SGEN) released fourth-quarter earnings on Thursday and gave investors a taste of what's to come later this year. With modest growth for Adcetris, its only drug on the market, investors should be focused on Seattle Genetics' pipeline and clinical trials that could further expand sales of Adcetris.

Metric

Q4 2016

Q4 2015

Year-Over-Year Change

Revenue

$105 million

$93 million

12.6%

Income from operations

($55.8 million)

($25.1 million)

N/A

Earnings per share

($0.39)

($0.18)

N/A

Data source: Seattle Genetics.

Image source: Getty Images.

Clay Siegall, Seattle Genetics' president and CEO, asked investors to look past 2017 guidance and see the bigger picture: "What is really important with Adcetris is not the sales we have now. What's really important is going toward the big items of [ECHELON-1] and [ECHELON-2], and you can even include ALCANZA in there."

On the delay of submitting the application for CTCL patients, Siegall didn't even want to call it that. "To me it's not a delay. To me it's taking advantage of an opportunity," he said. "I think we have a really good opportunity to end up with a bigger market if we can get a bigger label."

Management guided for Adcetris sales of $280 million to $300 million this year, which is 5.3% to 12.9% higher than last year's sales. Royalty revenue is expected to be in the $50 million to $55 million range, down from the $67.5 million in 2016, but last year included a $20 million milestone payment.

The difference between the bottom and top of guidance likely has to do with how many doctors prescribe Adcetris for CTCL off-label ahead of the FDA approval. But capturing those patients now versus next year isn't particularly important for Seattle Genetics' long-term value.

Brian Orelli has no position in any stocks mentioned. The Motley Fool recommends Seattle Genetics. The Motley Fool has a disclosure policy.

Dr. Orelli is a Senior Biotech Specialist. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007.

Read the original:
Seattle Genetics Earnings: Waiting on ECHELON - Motley Fool

Biotech Premarket Movers: Sage Therapeutics, Immunomedics, Myriad Genetics – TheStreet.com

Shares of Sage Therapeutics ( SAGE) were up 8.6% ahead of the opening bell on Monday, trading at $51.50. The Cambridge, Mass. company unveiled encouraging top-line results from part A of its phase 2 study of SAGE-217 for the treatment of major depressive disorder. "Understanding the caveats associated with open-label data, we are highly encouraged by the strong signal we achieved in this study, which met our internal criteria for achieving a positive signal and thus supported our plan to proceed to the double-blind, placebo-controlled part of the Phase 2 trial," said Sage CEO Jeff Jonas in a statement.

Meanwhile, Immunomedics ( IMMU) shares rose 8% to $5.65 after finishing Friday's trading session at $5.23, up 21.6%. The Morris Plains, N.J. company on Friday announced a global licensing agreement with Seattle Genetics ( SGEN) for sacituzumab govitecan, Immunomedics' solid tumor therapy candidate.

Other biotech stock movers on Monday morning include molecular diagnostic company Myriad Genetics ( MYGN) , whose shares were up 6.2%, to $16.98.

Follow this link:
Biotech Premarket Movers: Sage Therapeutics, Immunomedics, Myriad Genetics - TheStreet.com

Cocaine addiction a matter of genetics, UBC researchers say – Calgary Herald

Scientists at the University of B.C.have built a better mouse one that is indifferent to cocaine.

Unlike normal mice, the genetically engineered rodents did not show addictive behaviour even after repeated injections of the narcotic over days, suggesting that habitual drug use in humans may be a matter of genetics.

While the finding is unlikely to yield a pill that cures addiction anytime soon, it could lead to a test that identifies who is at greatest risk of addiction and enable people to act on that knowledge, saidShernaz Bamji, the lead author of a study published today by the journal Nature Neuroscience.

The finding provides a biochemical model for addiction based onprevious work at Johns Hopkins University in Baltimore, Md., that found people with genetic mutations associated with a class of proteins in the brain called cadherins are more prone to substance abuse.

Cadherin helps bind cells together and play a role inwhich brain circuits are strengthened during learning even learning that certain drugs deliver pleasure.

Although Bamji had theorized that higher levels of cadherin would lead to more addictive behaviour, the opposite turned out to be true.

To better understand its role, the researchers engineered mice to produce excessive cadherin proteins in their brains.

Bamji and her collaboratorsinjected normal and genetically engineered mice with cocaine and placed them in a distinctly decorated room within a multi-room cage. On alternating days the mice were placed in the other room and injected with saline, said co-author Andrea Globa.

After six days of alternating treatments, the mice wereallowed to move freely to any of the rooms in the cage.

The normal mice greatly preferred the cocaine-associated room, but the high-cadherin mice didnt much care for it, suggesting that the presence of extra cadherin had somehow interfered with the learned response to cocaine.

Normal mice always gravitate to the chamber where they received the drug, looking for that high, but the mutant mice didnt, said Bamji.

The answer to the mysterious result was found inside the membrane of brain cellsthemselves, where cadherin interfered with the ability of a specialized proteinreceptor to functionat the synapse, the point at which neurons communicatewith each other chemically toform memories.

Unable to strengthen the connection between synapses, the brains learning circuitry couldntretaincocaines pleasurable memory.

Addiction is a form of learning in the reward circuits of the brain, she said. Where you dont get synapse strengthening, you arent getting learning and you arent getting addiction.

However, because many synapsesin the brain use the same strategy to learn, a magic bullet or pill for addiction is a long way off.

Simply increasing cadherin would likely prevent (addicts)from learning anything new, she said. Thats not a very good trade-off.

Future research might uncover a protein or enzyme in the brainmore specific to addiction that functions only in the reward circuitry of the brain, which could be a target for medication.

rshore@postmedia.com

CLICK HERE to report a typo.

Is there more to this story? Wed like to hear from you about this or any other stories you think we should know about. Email vantips@postmedia.com.

View post:
Cocaine addiction a matter of genetics, UBC researchers say - Calgary Herald

College of Medicine graduate student launches genetics research start-up – Penn State News

HERSHEY, Pa. Olivier Noel is only 28 years old, but hes already changing the face of genetics research.

The Haitian native is in his sixth year of Penn State College of MedicinesMD/PhD Medical Scientist Training Programand was recently recognized by Forbes as one of the countrys brightest young entrepreneurs on its30 Under 30 list in the science industry. Hes the founder of DNAsimple, a startup aimed at accelerating genetics research by connecting DNA donors with research scientists. The company provides scientists with access to critically important samples, significantly speeding up the pace for genetics research.

People dont realize it can take years to get samples, but really only a month to get an assignment done which is a little bit ridiculous, Noel said. Its a problem for geneticists across the board. You can have a million dollars to do a study, but waste three years trying to get samples.

Noel explained a light bulb went off when he attended a genetics conference at the recommendation of Dr. Roger L. Ladda, whom he had been shadowing with the intent of focusing his residency on genetics.

The keynote speaker at the conference was talking about how he was studying a disease not really prevalent in the Western world, and the way they were able to get a DNA sample to validate was through Facebook. The joke at the time was that Facebook is the new way of doing genetics. I realized, wow, that worked well for one case but thats not the way science should get done, Noel said.

Noels big break was when the company was accepted into the Y Combinator program, which includes such notable alumni as Dropbox, Airbnb and Reddit. DNAsimple was one of 32 companies accepted from more than 6,500 applicants worldwide, he said. But he credits his doctoral advisors former Penn State faculty member Dr. Glenn S. Gerhard and Penn State College of Medicine Chair of Biochemistry and Molecular BiologyJames Broach for teaching him about genetics and exposing him to the Penn State Institute for Personalized Medicine.

Learn more about Noel and his work in this Penn State Medicine article.

Last Updated February 13, 2017

See the original post:
College of Medicine graduate student launches genetics research start-up - Penn State News

Genetics of height: It may be too complex for scientists to crack the code – Genetic Literacy Project

[W]hen the human genome was sequenced, scientists like [Joel Hirschhorn, a geneticist at Boston Childrens Hospital and the Broad Institute] thought they could plumb that data to track all the height genes.

That effort started slowly. But now, Hirschhorn says, For height there are about 700 variants known to affect height, each of them usually with a pretty small effect on height, usually like a millimeter or less.

Even so, the traits [Hirschhorn] found only explain about a quarter of the inherited height factors. And, frustratingly, for most of those variants scientists have no idea what they actually do.

Hirschhorn and his colleagues are expanding their already massive study of 700,000 subjects. That approach has drawn skepticism from some scientists, who think its a waste of effort.

David Goldstein, a professor of genetics at Columbia University, says an expanded effort could ultimately implicate every gene in existence, and that hardly helps scientists narrow down the biological factors that contribute to height.

Its likely scientists will never be able to figure out what these hundreds of common variants do to influence height, Goldstein says. Instead, a much better strategy is [to look] for rare variants that pack a big punch.

[The study can be found here.]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:Genetics of Height is Way Complex, It Turns Out

See the article here:
Genetics of height: It may be too complex for scientists to crack the code - Genetic Literacy Project

miRagen Therapeutics (MGEN) Completes Merger with Signal Genetics (SGNL) – StreetInsider.com

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Miragen Therapeutics, Inc. (Nasdaq: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced the completion of its merger with Signal Genetics, Inc. (Nasdaq: SGNL) , effective February 13, 2017. Concurrent with the closing of the merger, miRagen received gross proceeds of $40.7 million in new equity investment from a combination of current and new miRagen investors, including Fidelity Management and Research Company, Brace Pharma Capital, Atlas Venture, Boulder Ventures, JAFCO Co., Ltd., MP Healthcare Venture Management, MRL Ventures (a venture fund of Merck, known as MSD outside the United States and Canada), Remeditex Ventures, and others. Together with pre-merger cash on miRagens balance sheet, the combined company has approximately $60 million in cash and short-term investments.

Upon completion of the merger today, Signal was renamed Miragen Therapeutics, Inc. The combined company will commence trading on The NASDAQ Capital Market under the symbol MGEN on February 14, 2017.

The completion of this merger marks a significant step forward for miRagen, our investors and potentially thousands of patients awaiting a therapeutic option for their conditions, said miRagen President and CEO William S. Marshall, Ph.D. The equity investment aligns the companys cash resources with our plan to advance the first two clinical programs into additional trials and to develop a compelling pipeline of targeted product candidates, each focused on patient populations with few clinical options. We believe these transactions will help us create a more focused and well financed organization as we build an exciting enterprise, an innovative culture and value for current and future stockholders.

Following the completion of the financing and merger, the combined company has approximately 21.3 million shares of common stock outstanding.

miRagens stockholders, including those who invested in the concurrent financing, received common stock, representing approximately 95.2% of the outstanding shares. Signals stockholders retained approximately 4.8% of the combined company.

The combined company will operate under the leadership of Dr. Marshall, and the board of directors of the combined company is comprised of seven members: Bruce Booth, John Creecy, Thomas Hughes, Kevin Koch, Kyle Lefkoff, Joseph Turner and Dr. Marshall.

Wedbush PacGrow acted as placement agent for miRagen in the financing.

Here is the original post:
miRagen Therapeutics (MGEN) Completes Merger with Signal Genetics (SGNL) - StreetInsider.com

Mutant maize offers key to understanding plant growth – Phys.Org

February 13, 2017 From left, normal and mutant maize plants. Credit: UC Riverside

How plant cells divide and how that contributes to plant growth has been one of the longstanding unsolved mysteries of cell biology. Two conflicting ideas have fueled the mystery.

The first idea is that cells divide merely to fill space in plant tissue, and therefore the orientation of the division is unimportant to growth. In other words, the contribution of individual cell behavior to overall growth isn't very important.

The second idea is that individual cells are the basic unit of life and their individual programs eventually build an organism. In other words, each new cell created contributes to proper patterning of the tissue. In this case, the orientation of each cell's division is critical for how the plant tissue is patterned and also impacts growth.

New findings by a University of California, Riverside-led team of researchers, lend support to the second idea, that the orientation of cell division is critical for overall plant growth. The work was just published in the journal Proceedings of the National Academy of Sciences.

The researchers, led by Carolyn Rasmussen, an assistant professor of plant cell biology at UC Riverside and Pablo Martinez, a graduate student working in Rasmussen's lab, together with Anding Luo and Anne Sylvester at University of Wyoming, were working with a maize mutant, called tangled1, with known defects in growth and division plane orientation of cells. Division plane orientation refers to the positioning of new cell walls during division.

They used time-lapse live cell imaging that represented hundreds of hours of maize, (commonly called corn in the United States), cells dividing. The time-lapse of imaging allowed them to characterize a previously unknown delay during cell division stages in the maize mutant. This study clarified the relationship between growth, timely division progression and proper division plane orientation.

This study suggests that delays during division do not necessarily cause growth defects, but that improper placement of new cell walls together with delays during division causes growth defects. Therefore, division plane orientation is a critical but potentially indirect factor for growth.

The findings might have long-term implications for increasing agricultural production. For example, during the Green Revolution of the mid-20th century, researchers developed short-stature, or dwarf, wheat and rice varieties that led to higher yields and are credited with saving over a billion people from starvation. Understanding the molecular mechanisms of plant growth might contribute in the long-term to developing more suitable short-stature maize varieties.

The paper is called "Proper division plane orientation and mitotic progression together allow normal growth of maize."

Explore further: How plant cells regulate growth shown for the first time

More information: Proper division plane orientation and mitotic progression together allow normal growth of maize, PNAS, http://www.pnas.org/cgi/doi/10.1073/pnas.1619252114

Researchers have managed to show how the cells in a plant, a multicellular organism, determine their size and regulate their growth over time. The findings overturn previous theories in the field and are potentially significant ...

Among bacteria, the spirochetes are characterized by their spiral shape and remarkable lengthas much 50 times longer than most other bacteria. This can make cell elongation and division a laborious process. One of those ...

Cell division is a fundamental process of life, producing two cells from one single cell at each cell division. During animal development, a fertilized egg divides many times, increasing the number of cells, which are precisely ...

Researchers at the Institute of Molecular Biotechnology in Vienna have unravelled how a tiny microRNA molecule controls growth and differentiation of brain cells.

Modern genome sequencing methods used to measure the efficiency of synthesis of individual protein during cell division has found that the enzymes that make lipids and membranes were synthesized at much greater efficiency ...

A study conducted by a research team led by Michel Cayouette, Full IRCM Research Professor and Director of the Cellular Neurobiology research unit, in collaboration with a team led by Stphane Angers, Associate Professor ...

A new report from the Stowers Institute for Medical Research chronicles the embryonic origins of planaria, providing new insight into the animal's remarkable regenerative abilities.

How plant cells divide and how that contributes to plant growth has been one of the longstanding unsolved mysteries of cell biology. Two conflicting ideas have fueled the mystery.

Watching the smooth movement generated by hundreds of fish as they swim in unison is truly mesmerising. But it's not only its sheer beauty that makes it so hard to look away, for scientists, it's also the fact that its emergence ...

Recent evidence demonstrates that the origins of photosynthesis can be found in deep sea hydrothermal vents, where microbes evolved to obtain energy from ejected hydrogen sulfide and methane gases. These microbes are capable ...

A new study of songbird dehydration and survival risk during heat waves in the United States desert Southwest suggests that some birds are at risk of lethal dehydration and mass die-offs when water is scarce, and the risk ...

Scientists have discovered a new protein that likely will advance the search for new natural antibiotics, according to a study by Texas A&M AgriLife Research published Feb. 13 in the journal Nature Microbiology.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read this article:
Mutant maize offers key to understanding plant growth - Phys.Org

Roses are red, violets are bluewhat gives flowers those eye … – Phys.Org

February 13, 2017 by Cheryl Dybas Knock-your-eyes-out red: A flowering plant native to Mexico called early jessamine or red cestrum. Credit: Stacey Smith

To solve the mystery of why roses are red and violets are blue, scientists are peering into the genes of plant petals.

"When you ask anyone how one flower is different from another, for most of us, color is the feature that first comes to mind," says evolutionary biologist Stacey Smith of the University of Colorado Boulder.

Most people don't think about why a flower is a particular color, but it's an important question for biologists, says Prosanta Chakrabarty, a program director in the National Science Foundation's (NSF) Division of Environmental Biology, which funds Smith's research.

Smith and her team are "looking at the genetics of flower colors, and at changes in those colors over time," Chakrabarty says.

It all comes down to biochemistry

In nature, flowers come in hues that span the rainbow.

"On a microscopic level, the colors come from the biochemical composition of petal cells," Smith says.

Pigments are the main chemicals responsible. Plants contain thousands of pigment compounds, all of which belong to three major groups: flavonoids, carotenoids and betalains. Most flower colors come from flavonoids and carotenoids.

"In addition to giving flowers their colors, carotenoids and anthocyaninswhich are flavonoidshave antioxidant and other medicinal properties, including anti-cancer, antibacterial, antifungal and anti-inflammatory activity," says Simon Malcomber, a program director in NSF's Division of Environmental Biology.

Malcomber says the research could show how plants evolved to synthesize the carotenoids and anthocyanins that produce red flowers. "The results could be used in future drug discovery research," he says.

Much of Smith's work is focused on understanding how changes in flavonoid and carotenoid biochemistry relate to differences in flower colors. She and colleagues conduct research on the tomato family, a group of about 2,800 species that includes tomatoes, eggplants, chili peppers, tobacco and potatoes.

"These domesticated species don't have a terribly wide range of flower colors and patterns, but their wild relatives often do," Smith says. "So we study wild, or undomesticated, species, which are most diverse in South America."

Hot pursuit of red-hot color

Smith has had her share of adventures in the fieldlike the time she tried to find a plant with red flowers that lives at the base of a volcanic crater in Ecuador.

"It was my very first field trip, and I wasn't super-savvy," Smith says. "I took a bus to the outside of the crater, dragged my suitcase up to the rim then down into the crater, assuming there would be a village and a way to get out. There was neither. Thankfully, there was a park station nearby where I was able to stay overnight. I found the species in full flower in the forest the next day."

Smith is currently in hot pursuit of an answer to the question: When did red flowers first appear in the tomato family? "We thought that red flowers might have evolved many times independently of each other because red-flowered species are scattered among many branches of this family tree," she says.

Just 34 species in the entire tomato family, however, have red flowers.

"With such a small number, we can take samples of every one of these species to find out whether it represents an independent origin, and to determine the biochemistry of how it makes red flowers," Smith says.

She and other biologists traveled from Brazil to Colombia to Mexico to track down red flowers and measure their pigments. "We found surprising patterns," Smith says, "including that nearly every red-flowered species represents a new origin of the color, so red flowers have evolved at least 30 different times."

While the researchers expected that flowers would be red due to the presence of red pigments, they found that plants often combine yellow-orange carotenoids with purple anthocyanins to produce red flowers.

"Our studies are now aimed at tracing the entire genetic pathway by which plants make flower colors and identifying genetic changes to see if there are common mechanisms," Smith says.

The scientists want to know, for example, what changes have taken place since flowers first became red.

Answers in a petunia

"We're focusing on a single branch of the tomato family [petunias], creating an evolutionary history and conducting measurements of gene expression, pigment production and flower color," says Smith.

Petunias and their colorful relatives are good choices for this research, according to Smith.

"Most of us have seen the tremendous variation in petunia colors at our local nurseries, and indeed, petunias have served as models for studying flower color and biochemistry for decades."

Few people, though, are aware of the variation in petunias' wild relatives, most of which are found in Argentina and Brazil. "We're harnessing this natural diversity, as well as genetic information already available from ornamental petunias, to reconstruct the evolutionary history of flower colors," says Smith.

"If earlier studies taught us anything," she adds, "we shouldn't expect flowers to play by the rules."

Will roses always be red, and violets blue?

Explore further: Turning pretty penstemon flowers from blue to red

While roses are red, and violets are blue, how exactly do flower colors change?

Flower colors that contrast with their background are more important to foraging bees than patterns of colored veins on pale flowers according to new research, by Heather Whitney from the University of Cambridge in the UK, ...

(Phys.org) -- A team of researchers in Australia has shown that the evolution of flowers in that country was driven by the preferences of bees, rather than the other way around. In their paper published in the Proceedings ...

Researchers have uncovered the secret recipe to making some petunias such a rare shade of blue. The findings may help to explain and manipulate the color of other ornamental flowers, not to mention the taste of fruits and ...

Male hummingbirds drive female birds away from their preferred yellow-flowered plant, which may have implications for flower diversification, according a study published Jan. 27, 2016 in the open-access journal PLOS ONE by ...

Roses are red, violets are blue. Everybody knows that, but what makes them so? Although plant breeders were aware of some of the genes involved, there was as yet no quantitative study of how pigment turns a flower red, blue ...

A new report from the Stowers Institute for Medical Research chronicles the embryonic origins of planaria, providing new insight into the animal's remarkable regenerative abilities.

How plant cells divide and how that contributes to plant growth has been one of the longstanding unsolved mysteries of cell biology. Two conflicting ideas have fueled the mystery.

Watching the smooth movement generated by hundreds of fish as they swim in unison is truly mesmerising. But it's not only its sheer beauty that makes it so hard to look away, for scientists, it's also the fact that its emergence ...

Recent evidence demonstrates that the origins of photosynthesis can be found in deep sea hydrothermal vents, where microbes evolved to obtain energy from ejected hydrogen sulfide and methane gases. These microbes are capable ...

A new study of songbird dehydration and survival risk during heat waves in the United States desert Southwest suggests that some birds are at risk of lethal dehydration and mass die-offs when water is scarce, and the risk ...

Scientists have discovered a new protein that likely will advance the search for new natural antibiotics, according to a study by Texas A&M AgriLife Research published Feb. 13 in the journal Nature Microbiology.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

See the original post here:
Roses are red, violets are bluewhat gives flowers those eye ... - Phys.Org